Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations

References

• Bezzio C, Saibeni S, Variola A, et al. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020;69(7):1213–1217.
   PubMed Web of Science ®Google Scholar
• Aziz M, Fatima R, Haghbin H, et al. The incidence and outcomes of COVID-19 in IBD patients: a rapid review and meta-analysis. Inflamm Bowel Dis. 2020;26(10):e132–e133.
   PubMed Web of Science ®Google Scholar
• Allocca M, Chaparro M, Gonzalez HA, et al. Patients with inflammatory bowel disease are not at increased risk of COVID-19: a large multinational cohort study. J Clin Med. 2020;9(11):3533.
   Web of Science ®Google Scholar
• Maconi G, Bosetti C, De Monti A, et al. Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population. Dig Liver Dis. 2021;53(3):263–270.
   PubMedGoogle Scholar
• Norsa L, Indriolo A, Sansotta N, et al. Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy. Gastroenterology. 2020;159(1):371.
   PubMed Web of Science ®Google Scholar
• An P, Ji M, Ren H, et al. Protection of 318 inflammatory bowel disease patients from the outbreak and rapid spread of COVID-19 infection in Wuhan, China. The Lancet. 2020;5:525–527.
   Google Scholar
• Taxonera C, Sagastagoitia I, Alba C, et al. 2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2020;52(2):276–283.
   PubMed Web of Science ®Google Scholar
• Khan N, Patel D, Xie D, et al. Are patients with inflammatory bowel disease at an increased risk of developing SARS-CoV-2 than patients without inflammatory bowel disease? Results from a nationwide veterans’ affairs cohort study. Am J Gastroenterol. 2020. DOI:10.14309/ajg.0000000000001012
   Web of Science ®Google Scholar
• Lukin DJ, Kumar A, Hajifathalian K, et al. Baseline disease activity and steroid therapy stratify risk of COVID-19 in patients with inflammatory bowel disease. Gastroenterology. 2020;159(4):1541–1544.
   PubMed Web of Science ®Google Scholar
• Brenner EJ, Ungaro RC, Gearry RB, et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. 2020;159(2):481–491.
   PubMed Web of Science ®Google Scholar
• Burke KE, Kochar B, Allegretti JR, et al. Immunosuppressive therapy and risk of COVID-19 infection in patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2021;27(2):155–161.
   PubMed Web of Science ®Google Scholar
• Guerra I, Algaba A, Jiménez L, et al. Incidence, clinical characteristics, and evolution of SARS-CoV-2 infection in patients with inflammatory bowel disease: a single-center study in Madrid, Spain. Inflamm Bowel Dis. 2021;27(1):25–33.
   PubMed Web of Science ®Google Scholar
• Siegel CA, Christensen B, Kornbluth A, et al. Guidance for restarting inflammatory bowel disease therapy in patients who withheld immunosuppressant medications during COVID-19. J Crohns Colitis. 2020;14(3):S769–S773.
   PubMedGoogle Scholar
• Kennedy NA, Jones GR, Lamb CA, et al. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut. 2020;69(6):984–990.
   PubMed Web of Science ®Google Scholar
• Rubin DT, Feuerstein JD, Wang AY, et al. AGA clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary. Gastroenterology. 2020;159(1):350–357.
   PubMed Web of Science ®Google Scholar
• Rubin DT, Abreu MT, Rai V, et al. International organization for the study of inflammatory bowel disease. management of patients with Crohn’s disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an international meeting. Gastroenterology. 2020;159(1):6–13.
   PubMed Web of Science ®Google Scholar
• Ungaro RC, Brenner EJ, Gearry RB, et al. Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut. 2021;70(4):725–732.
   PubMed Web of Science ®Google Scholar
• Sebastian S, Walker GJ, Kennedy NA, et al. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021;6(4):271–281.
   PubMed Web of Science ®Google Scholar
• Ng SC, Mak JWY, Hitz L, et al. COVID-19 pandemic: which IBD patients need to be scoped-who gets scoped now, who can wait, and how to resume to normal. J Crohns Colitis. 2020;14(3):S791–S797.
   PubMedGoogle Scholar
• Soetikno R, Teoh AYB, Kaltenbach T, et al. Considerations in performing endoscopy during the COVID-19 pandemic. Gastrointest Endosc. 2020;92(1):176–183.
   PubMed Web of Science ®Google Scholar
• Sultan S, Lim JK, Altayar O, et al. AGA rapid recommendations for gastrointestinal procedures during the COVID-19 pandemic. Gastroenterology. 2020;159(2):739–758.
   PubMed Web of Science ®Google Scholar
• Iacucci M, Cannatelli R, Labarile N, et al. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period. Lancet Gastroenterol Hepatol. 2020;5(6):598–606.
   PubMed Web of Science ®Google Scholar
• Furfaro F, Vuitton L, Fiorino G, et al. SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience. Nat Rev Gastroenterol Hepatol. 2020;17(8):507–516.
   PubMed Web of Science ®Google Scholar
• Neumann H, Emura F, Bokemeyer B, et al. Practical advice for management of inflammatory bowel diseases patients during the COVID-19 pandemic: World Endoscopy Organization Statement. Dig Endosc. 2020;32(5):658–662.
   PubMed Web of Science ®Google Scholar
• Tian Y, Rong L, Nian W, et al. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843–851.
   PubMed Web of Science ®Google Scholar
• Fiorino G, Allocca M, Furfaro F, et al. Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: the Humanitas, Milan, Experience. J Crohns Colitis. 2020;14(9):1330–1333.
   PubMed Web of Science ®Google Scholar
• Chiu PWY, Ng SC, Inoue H, et al. Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements). Gut. 2020;69(6):991–996.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yu Q, Farraye FA, et al. Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice. Intest Res. 2020. DOI:10.5217/ir.2020.00037
   Google Scholar
• Magro F, Gionchetti P, Eliakim R, et al. Third European Evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11(6):649–670.
   PubMed Web of Science ®Google Scholar
• Rieder F, Latella G, Magro F, et al. European Crohn’s and colitis organisation topical review on prediction, diagnosis and management of fibrostenosing Crohn’s disease. J Crohns Colitis. 2016;10(8):873–885.
   PubMed Web of Science ®Google Scholar
• Aabakken L, Karlsen TH, Albert J, et al. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy. 2017;49(6):588–608.
   PubMed Web of Science ®Google Scholar
• Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666–689.
   PubMed Web of Science ®Google Scholar
• Ten Hove JR, Shah SC, Shaffer SR, et al. Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: results of a 15-year multicentre, multinational cohort study. Gut. 2019;68(4):615–622.
   PubMed Web of Science ®Google Scholar
• Choi CS, Ignjatovic-Wilson A, Askari A, et al. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer. Am J Gastroenterol. 2015;110(10):1461–1471.
   PubMed Web of Science ®Google Scholar
• Alexander JL, Moran GW, Gaya DR, et al. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement. Lancet Gastroenterol Hepatol. 2021;6(3):218–224.
   PubMed Web of Science ®Google Scholar
• Siegel CA, Melmed GY, McGovern DP, et al. SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. Gut. 2021;70(4):635–640.
   PubMed Web of Science ®Google Scholar
• 7th Interview COVID-19 ECCO Taskforce. [cited 2021 Feb 12]. Available from: https://www.ecco-ibd.eu/images/6_Publication/6_8_Surveys/7th_Interview_FinalVersion.pdf
   Google Scholar
• Elkayam O, Bashkin A, Mandelboim M, et al. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum. 2010;39(6):442–444.
   PubMed Web of Science ®Google Scholar
• Andrisani G, Frasca D, Romero M, et al. Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants. J Crohns Colitis. 2013;7(4):301–307.
   PubMed Web of Science ®Google Scholar
• Chen Y, Hu S, Wu H, et al. Patterns of care for inflammatory bowel disease in China during the COVID-19 pandemic. Lancet Gastroenterol Hepatol. 2020;5(7):632–634.
   PubMed Web of Science ®Google Scholar
• D’Amico F, Rahier JF, Leone S, et al. Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey. Lancet Gastroenterol Hepatol. 2020;5(7):631–632.
   PubMed Web of Science ®Google Scholar
• Grunert PC, Reuken PA, Stallhofer J, et al. Inflammatory bowel disease in the COVID-19 pandemic – the patients’ perspective. J Crohns Colitis. 2020;14(12):1702–1708.
   Web of Science ®Google Scholar
• 2nd Interview COVID-19 ECCO Taskforce. [cited 2020 Mar 20]. Available from: https://www.ecco-ibd.eu/images/6_Publication/6_8_Surveys/7th_Interview_FinalVersion.pdf
   Google Scholar
• Costantino A, Noviello D, Mazza S, et al. Trust in telemedicine from IBD outpatients during the COVID-19 pandemic. Dig Liver Dis. 2021;53(3):291–294.
   PubMedGoogle Scholar